Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Building resilience for transgender and nonbinary people using Metaverse support groups

Official title: Evaluating the Efficacy of Virtual Support Groups Fostering Resilience for Gender Diverse People: a Randomized Clinical Trial in the Metaverse

Run by University of Bucharest · NCT06959992 · Data updated 2026-11-12

This project will test whether joining support groups in a Metaverse virtual world helps transgender and nonbinary people strengthen resilience and self-compassion compared with an online forum or waitlist.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment123 (estimated)
SponsorUniversity of Bucharest
Academic / other
Locations1 site (Bucharest, Bucharest)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 28, 2026
Trial IDNCT06959992 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who identify as transgender, nonbinary, or otherwise gender diverse (including those questioning) with a stable gender identity, no formal mental disorder diagnosis, and the ability to access online Metaverse or forum sessions are ideal candidates.

Probably not a fit

People under 18, individuals with a formal psychiatric diagnosis, those not part of the gender-minority population, or people unable or unwilling to use online/virtual platforms are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized clinical trial assigns gender-diverse adults to one of three arms: an immersive Metaverse support group, a standard online asynchronous forum, or a waitlist control. Group sessions use avatar customization and social interaction to encourage expression of gender identity and practice handling social challenges in a virtual environment. Participants complete measures before the intervention, mid-sessions, after the intervention, and at a 3-month follow-up to track changes in resilience, self-compassion, and well-being. The target enrollment is 123 people (about 41 per arm) to allow detection of small-to-medium effects while accounting for dropouts.

Why it matters

Potential benefit: If successful, this approach could offer a scalable virtual option that improves resilience and self-compassion in gender-diverse adults.

How similar studies have gone: Online peer-support and forum interventions have shown some benefits for well-being in gender-minority groups, but immersive Metaverse-based support groups are largely novel and not yet widely tested in randomized trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Transgender and nonbinary individuals with a stable gender-identity or questioning

Exclusion Criteria:

* Presence of acute psychiatric instability (e.g., acute psychotic symptomatology or acute suicide risk)
* Not being part of the transgender population
* Younger than 18

Where it's running

  • University of Bucharest
    Bucharest, Bucharest, Romania
    Recruiting

Study contacts

  • Principal investigator: Cezar Giosan, PhD — University of Bucharest
  • Study coordinator: Cezar Giosan, PhD
  • Email: giosan@outlook.com
  • Phone: +40730908050

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.